Alphatec (ATEC) Expected to Announce Earnings on Wednesday

Alphatec (NASDAQ:ATEC) is expected to issue its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.19) per share and revenue of $172.74 million for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Alphatec Stock Performance

Shares of Alphatec stock opened at $10.76 on Tuesday. The company has a debt-to-equity ratio of 30.21, a current ratio of 2.32 and a quick ratio of 1.15. The firm has a market cap of $1.53 billion, a price-to-earnings ratio of -8.41 and a beta of 1.43. The stock’s 50-day moving average is $10.50 and its 200-day moving average is $8.30. Alphatec has a one year low of $4.88 and a one year high of $15.41.

Analyst Ratings Changes

ATEC has been the topic of several research reports. Barclays boosted their target price on Alphatec from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Wednesday, January 22nd. Needham & Company LLC increased their target price on shares of Alphatec from $13.00 to $16.00 and gave the stock a “buy” rating in a report on Monday, January 13th. Finally, HC Wainwright reiterated a “buy” rating and issued a $20.00 price target on shares of Alphatec in a research note on Tuesday, January 14th. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $17.56.

Insider Buying and Selling at Alphatec

In other news, EVP David Sponsel sold 58,283 shares of the firm’s stock in a transaction that occurred on Monday, January 13th. The stock was sold at an average price of $10.71, for a total value of $624,210.93. Following the completion of the sale, the executive vice president now directly owns 502,311 shares of the company’s stock, valued at $5,379,750.81. This trade represents a 10.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Patrick Miles sold 50,000 shares of Alphatec stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $12.03, for a total value of $601,500.00. Following the transaction, the chief executive officer now owns 6,152,544 shares of the company’s stock, valued at $74,015,104.32. This represents a 0.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 222,376 shares of company stock worth $2,557,148 over the last quarter. 22.80% of the stock is currently owned by insiders.

Alphatec Company Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.